- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in Covaxin
Bharat Biotech To Produce 700 Mn Covaxin Doses Annually
According to a press release issued by the Hyderabad-based vaccine maker, manufacturing scale-up has been carried out in a stepwise manner across multiple facilities at Hyderabad and Bangalore.
Read More
COVID Vaccine Approval Procedure Takes Longer Time: WHO official, As Covaxin decision awaited
Ryan was responding to a question during a recent virtual Q&A on whether there will be a definitive answer on Covaxin EUL by October 26.
Read More
WHO's Technical Group To Meet On Oct 26 To Consider Emergency Use Listing Of Covaxin
The WHO experts are currently reviewing this information and if it addresses all questions raised, the WHO assessment will be finalised next week.
Read More
WHO To Take Final Decision Next Week On Approval To Bharat Biotech's Covaxin
WHO experts are currently reviewing this info & if it addresses all questions raised, WHO assessment will be finalized next week, WHO said in a series of tweets.
Read More
Centre Got Over 65.25 Crore Covishield Doses, 9.1 Crore Covaxin Jabs Till September 19
The SII has informed the government that it will be able to supply around 22 crore doses of Covishield in October.
Read More
IIL To Make 10 Million Doses Of Covaxin Drug Substance From December
Lauding the efforts of the PSU for its ability to roll out the vaccine drug substance in record time, Union Minister Parshottam Rupala formally handed over the drug substance to Bharat Biotech, makers of Covaxin
Read More
Paediatric Covaxin: Bharat Biotech Completes Phase 2/3 Trials
On the production levels of Covaxin, Ella said 100 million doses per month can be possible if the other manufacturing partners are fully geared up with safety and other parameters are in place.
Read More
Bharat Biotech Awaits Feedback From WHO For Covaxin Emergency Use Listing
As a responsible manufacturer with past approvals for its other vaccines, the company said it would not find it appropriate to speculate or comment on approval process and its timelines
Read More
WHO's Approval For Covaxin Likely This Month
Covaxin is one of the six vaccines that have received emergency use authorisation from India's drug regulator and is being used in the nationwide inoculation programme, along with Covishield and Sputnik V.
Read More
ABB Commissions ACS560 Drives At Bharat Biotech''s Facility For Safe Manufacturing Of Covaxin
The drives are also installed at other pharmaceutical companies in India, which are manufacturing COVID-19 vaccines for the country
Read More
Gujarat: First Commercial Batch Of Covaxin Released From Bharat Biotech's New Plant
The government had earlier this month given approval to Bharat Biotech's Ankleshwar-based manufacturing plant to produce anti-COVID-19 vaccine Covaxin.
Read More
Vaccines For Children May Be Available By September: National Institute Of Virology
Hopefully the results will be available soon and they will be presented to regulators. Probably by September or just after September, we may have a vaccine for children this is Covaxin, says Priya Abraham, Director of the National Institute of Virology
Read More
Mixing Of Covaxin & Covishield: Efficacy Check
The puzzling question that is arising as of now is about the contrasting effects of the two vaccines on protection and potency.
Read More
Govt Approves Bharat Biotech's Ankleshwar Plant To Produce Covaxin: Mandaviya
The approval would help increase availability of COVID-19 vaccines in the country, he added.
Read More
Only Marginal Difference In Purchase Price Of Covishield, Covaxin For Centre: MoS Health
The total doses of vaccine that would be available to a state and UT, is provided to them 15 days in advance, so as to enable them to plan for acceleration of vaccination coverage while being cognizant of the available vaccines
Read More